Method for assessing proliferation inhibiting effect of inhibitor, and method for determining sensitivity of tumor cell to inhibitor
    2.
    发明申请
    Method for assessing proliferation inhibiting effect of inhibitor, and method for determining sensitivity of tumor cell to inhibitor 审中-公开
    评估抑制剂增殖抑制作用的方法,以及确定肿瘤细胞对抑制剂敏感性的方法

    公开(公告)号:US20080090254A1

    公开(公告)日:2008-04-17

    申请号:US11905027

    申请日:2007-09-27

    IPC分类号: G01N33/53

    摘要: A method for assessing the proliferation inhibiting effect of a receptor tyrosine kinase inhibitor is described. In the method, a cytoplasm is separated from a tumor cell to prepare a sample containing various receptor tyrosine kinases. The prepared sample is treated with the inhibitor. The receptor tyrosine kinases in the treated sample, and a substrate for at least two kinds of receptor tyrosine kinases are contacted. The phosphorylated substrate is detected, and the activity value of the receptor tyrosine kinases is measured based on the detection result. The proliferation inhibiting effect is assessed based on the resulting activity value.

    摘要翻译: 描述了用于评估受体酪氨酸激酶抑制剂的增殖抑制作用的方法。 在该方法中,从肿瘤细胞分离细胞质以制备含有各种受体酪氨酸激酶的样品。 制备的样品用抑制剂处理。 处理的样品中的受体酪氨酸激酶和至少两种受体酪氨酸激酶的底物接触。 检测磷酸化底物,并根据检测结果测定受体酪氨酸激酶的活性值。 基于得到的活性值评估增殖抑制作用。

    Method for measuring kinase activity
    3.
    发明申请
    Method for measuring kinase activity 审中-公开
    测定激酶活性的方法

    公开(公告)号:US20070238141A1

    公开(公告)日:2007-10-11

    申请号:US11729901

    申请日:2007-03-30

    IPC分类号: C12Q1/48 G01N33/53

    CPC分类号: C12Q1/485 G01N33/573

    摘要: A method for measuring the activity of a receptor kinase present in a cell membrane of a cell is described. The method comprises steps of preparing a sample containing the receptor kinase by separating a cytoplasm from the cell, contacting the receptor kinase in the sample with a substrate to phosphorylate the substrate with the activity of the receptor kinase, binding a labeling substance to the phosphorylated substrate, and measuring the activity of the receptor kinase based on a result of detection of the labeling substance bound to the phosphorylated substrate.

    摘要翻译: 描述了测定存在于细胞的细胞膜中的受体激酶的活性的方法。 该方法包括以下步骤:通过从细胞分离细胞质来制备含有受体激酶的样品,使样品中的受体激酶与底物接触,以使受体激酶活性磷酸化底物,将标记物质结合到磷酸化底物 ,并且基于与磷酸化底物结合的标记物质的检测结果测量受体激酶的活性。

    Tyrosine kinse substrate
    5.
    发明申请
    Tyrosine kinse substrate 审中-公开
    酪氨酸激酶底物

    公开(公告)号:US20080003630A1

    公开(公告)日:2008-01-03

    申请号:US11819236

    申请日:2007-06-26

    IPC分类号: C12Q1/48 C07K14/00

    摘要: A tyrosine kinase substrate is described. The tyrosine kinase substrate comprises a fusion protein which comprises a protein for labeling and a specific peptide fused with the protein for labeling. The specific peptide has an amino acid sequence including a glutamic acid residue and a tyrosine residue. The tyrosine kinase substrate is capable of being phosphorylated by a plurality of kinds of tyrosine kinases.

    摘要翻译: 描述了酪氨酸激酶底物。 酪氨酸激酶底物包含融合蛋白,其包含用于标记的蛋白质和与用于标记的蛋白质融合的特异性肽。 特定肽具有包含谷氨酸残基和酪氨酸残基的氨基酸序列。 酪氨酸激酶底物能够被多种酪氨酸激酶磷酸化。

    METHOD FOR ASSESSING EFFICACY OF COMBINATION CHEMOTHERAPY, AND PROGRAM AND DEVICE FOR ASSESSING THE SAME
    6.
    发明申请
    METHOD FOR ASSESSING EFFICACY OF COMBINATION CHEMOTHERAPY, AND PROGRAM AND DEVICE FOR ASSESSING THE SAME 审中-公开
    用于评估组合治疗效果的方法,以及用于评估其的程序和装置

    公开(公告)号:US20120278000A1

    公开(公告)日:2012-11-01

    申请号:US13457081

    申请日:2012-04-26

    IPC分类号: G06F19/00

    摘要: A method for assessing an efficacy of combination chemotherapy, comprising: a first obtaining process for obtaining a specific activity value of Cyclin Dependent Kinase (CDK) 1 and a specific activity value of CDK2 in a biological sample including a carcinoma cell collected from a cancer patient; a second obtaining process for obtaining a GSTπ expression level in the biological sample; and an assessment process for assessing the efficacy of the combination chemotherapy on the cancer patient based on the specific activity values of CDK1 and CDK2 obtained in the first obtaining process and the GSTπ expression level obtained in the second obtaining process.

    摘要翻译: 一种评估联合化疗疗效的方法,包括:获得细胞周期蛋白依赖性激酶(CDK)1的比活性值的第一获得方法和包含从癌症患者收集的癌细胞的生物样品中CDK2的比活性值 ; 获得GST&pgr的第二获取过程 生物样品中的表达水平; 以及基于在第一获得方法和GST&pgr中获得的CDK1和CDK2的比活性值来评估联合化疗对癌症患者的功效的评估过程。 在第二获得过程中获得的表达水平。

    EFFECT PREDICTING APPARATUS, COMPUTER PROGRAM PRODUCT, AND METHOD FOR PREDICTING AN EFFECT
    7.
    发明申请
    EFFECT PREDICTING APPARATUS, COMPUTER PROGRAM PRODUCT, AND METHOD FOR PREDICTING AN EFFECT 审中-公开
    效果预测装置,计算机程序产品和预测效果的方法

    公开(公告)号:US20100250483A1

    公开(公告)日:2010-09-30

    申请号:US12569130

    申请日:2009-09-29

    IPC分类号: G06N5/02

    CPC分类号: G16C20/30 G16B25/00

    摘要: An effect predicting apparatus for predicting an effect of anthracycline anticancer drugs, comprising: a display, a processor, and a memory, under control of said processor, including software instructions adapted to enable the processor to perform operations, comprising: acquiring a CDK parameter based on a first CDK parameter and a second CDK parameter; acquiring an expression level of glutathione; comparing the CDK parameter with a CDK threshold value, and the expression level of glutathione with a glutathione threshold value; predicting an effect of anthracycline anticancer drugs based on the result of the comparison; and displaying the result of the prediction. A computer program product and a method for predicting an effect are also disclosed.

    摘要翻译: 一种用于预测蒽环类抗癌药物的效果的效果预测装置,包括:在所述处理器的控制下的显示器,处理器和存储器,包括适于使处理器执行操作的软件指令,包括:基于CDK参数获取 第一个CDK参数和第二个CDK参数; 获得谷胱甘肽的表达水平; 将CDK参数与CDK阈值进行比较,以及谷胱甘肽阈值的谷胱甘肽的表达水平; 基于比较结果预测蒽环类抗癌药物的作用; 并显示预测结果。 还公开了一种用于预测效果的计算机程序产品和方法。